Health AI Central
Share:
Peer-Reviewed Publication
J Med Chem2025;68(22):23641-23642.November 27, 2025Editorial

Structural Biology Enabling Drug Discovery.

David E Heppner1, Simone V Bigi-Botterill2, Andrew P Riley3, Kelly Chibale4, Craig W Lindsley5
1Department of Chemistry, University at Buffalo, The State University of New York, Buffalo, New York 14260, United States.
2Exscientia, Boston, Massachusetts 02109, United States.
3Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois 60612, United States.
4Holistic Drug Discovery and Development (H3D) Centre, Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch 7701, South Africa.
5Vanderbilt Institute of Chemical Biology Program in Drug Discovery, Department of Pharmacology, Vanderbilt Medical Center, Nashville, Tennessee 37232, United States.
PubMed DOI

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.